Cargando…

Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer

Detalles Bibliográficos
Autores principales: Adamo, Barbara, Ricciardi, Giuseppina Rosaria Rita, Ieni, Antonio, Franchina, Tindara, Fazzari, Carmine, Sanò, Maria Vita, Angelico, Giuseppe, Caruso, Michele, Tuccari, Giovanni, Adamo, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368234/
https://www.ncbi.nlm.nih.gov/pubmed/30783520
http://dx.doi.org/10.18632/oncotarget.26650
_version_ 1783393948573630464
author Adamo, Barbara
Ricciardi, Giuseppina Rosaria Rita
Ieni, Antonio
Franchina, Tindara
Fazzari, Carmine
Sanò, Maria Vita
Angelico, Giuseppe
Caruso, Michele
Tuccari, Giovanni
Adamo, Vincenzo
author_facet Adamo, Barbara
Ricciardi, Giuseppina Rosaria Rita
Ieni, Antonio
Franchina, Tindara
Fazzari, Carmine
Sanò, Maria Vita
Angelico, Giuseppe
Caruso, Michele
Tuccari, Giovanni
Adamo, Vincenzo
author_sort Adamo, Barbara
collection PubMed
description
format Online
Article
Text
id pubmed-6368234
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-63682342019-02-19 Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer Adamo, Barbara Ricciardi, Giuseppina Rosaria Rita Ieni, Antonio Franchina, Tindara Fazzari, Carmine Sanò, Maria Vita Angelico, Giuseppe Caruso, Michele Tuccari, Giovanni Adamo, Vincenzo Oncotarget Correction Impact Journals LLC 2019-01-25 /pmc/articles/PMC6368234/ /pubmed/30783520 http://dx.doi.org/10.18632/oncotarget.26650 Text en Copyright: © 2019 Adamo et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Correction
Adamo, Barbara
Ricciardi, Giuseppina Rosaria Rita
Ieni, Antonio
Franchina, Tindara
Fazzari, Carmine
Sanò, Maria Vita
Angelico, Giuseppe
Caruso, Michele
Tuccari, Giovanni
Adamo, Vincenzo
Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
title Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
title_full Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
title_fullStr Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
title_full_unstemmed Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
title_short Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
title_sort correction: the prognostic significance of combined androgen receptor, e-cadherin, ki67 and ck5/6 expression in patients with triple negative breast cancer
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368234/
https://www.ncbi.nlm.nih.gov/pubmed/30783520
http://dx.doi.org/10.18632/oncotarget.26650
work_keys_str_mv AT adamobarbara correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer
AT ricciardigiuseppinarosariarita correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer
AT ieniantonio correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer
AT franchinatindara correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer
AT fazzaricarmine correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer
AT sanomariavita correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer
AT angelicogiuseppe correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer
AT carusomichele correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer
AT tuccarigiovanni correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer
AT adamovincenzo correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer